Company / Current Liabilities per Share
BioNexus Gene Lab Corp Current Liabilities per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$0.29
FY2025
5-year range
$0.01 / $0.29
FY2021-FY2025
Trend
+162.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Liabilities per Share has fluctuated over the past 7 years, ranging from $0.00 in FY2019 to $0.29 in FY2025.
Based on SEC 10-K filings.
0.29 in FY2025 with a 5-year CAGR of +54.6%.
Increased from $0.11 to $0.29 over the past 2 years.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- +191.5%
- 5-Year CAGR
- +54.6%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, current liabilities per share increased 162.5% year-over-year.
- Lowest current liabilities per share in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 5.27 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.29 | +162.5% |
| FY2024 | $0.11 | -2.0% |
| FY2023 | $0.11 | +862.5% |
| FY2022 | $0.01 | -13.9% |
| FY2021 | $0.01 | -58.6% |
| FY2020 | $0.03 | +4651.8% |
| FY2019 | $0.00 | - |
As of FY2025 · SEC Form 10-K · Last checked Jun 21, 2026